OKYO PHARMA LTD Aktie - Unternehmensdaten & Kurse - GG00BD3FV870 | MoneyPeak

OKYO PHARMA LTD

Share · GG00BD3FV870 · A2JQ3D (XLON)

No Price

n/a

Share Float & Liquidity

Free Float 0,52 %

Shares Float 8,54 M

Shares Outstanding 1,66 B

Company Profile for OKYO PHARMA LTD Share

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Company Data

Name OKYO PHARMA LTD

Company OKYO Pharma Limited

Website https://www.okyopharma.com

Primary Exchange

London

WKN A2JQ3D

ISIN GG00BD3FV870

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Gary S. Jacob

Market Capitalization 23 Mio

Country United Kingdom

Currency EUR

Employees 0,0 T

Address 55 Park Lane, W1K 1NA London

IPO Date 2018-07-17

Ticker Symbols

Name	Symbol
London	OKYO.L

More Shares

Investors who hold OKYO PHARMA LTD also have the following shares in their portfolio:

CITIGROUP INC 11/22 Bond

PJSC Saratov Oil Refinery Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025